Saroj Regmi
About Saroj Regmi
Saroj Regmi is a Postdoctoral Fellow at the National Institutes of Health, where he has worked since 2015. He has a background in biology and philosophy, holding doctorates from the Geisel School of Medicine at Dartmouth, and has experience in various research roles across multiple institutions.
Work at National Institutes of Health
Saroj Regmi has been a Postdoctoral Fellow at the National Institutes of Health (NIH) since 2015. In this role, he focuses on utilizing CRISPR-based techniques to investigate the roles of Nuclear Pore Complex constituents in mammalian cells. He also develops Drosophila mutants using CRISPR/Cas9 technology to further study these constituents. Additionally, he mentors NIH Post-Bac Intramural Research Training Award fellows, guiding their projects which have received various accolades.
Education and Expertise
Saroj Regmi studied at the Geisel School of Medicine at Dartmouth, where he earned a Doctor of Philosophy in Biology and Philosophy from 2008 to 2015. Prior to this, he obtained a Bachelor of Science in Biology from Jacobs University Bremen, studying from 2005 to 2008. His educational background provides a strong foundation for his research in molecular biology, particularly in the application of CRISPR technology.
Background
Saroj Regmi began his academic journey at Jacobs University Bremen, where he completed his Bachelor of Science in Biology. He then pursued graduate studies at Dartmouth College, where he worked for seven years as a Graduate Student. His early research experiences include a month-long Bachelor’s thesis at the Max Planck Institute for Marine Microbiology in Germany and a summer internship at the Marine Biological Laboratory in Massachusetts.
Research Techniques and Applications
In his current research, Saroj Regmi employs CRISPR-based techniques to explore the functions of Nuclear Pore Complex constituents in mammalian cells. He is involved in developing Drosophila mutants through CRISPR/Cas9 technology, which aids in the understanding of these cellular components. Additionally, he creates assays for high-throughput screening applications, contributing to advancements in molecular biology research.